Table 1

Baseline demographics

Age (years)

Disease duration (years)

SLEDAI

SDI

Follow-up time (years)

CAC (n = 142)

43.3 ± 9.9

12.0 ± 8.4

3.8 ± 3.5

1.5 ± 1.6

3.25 ± 0.35

AS (n = 106)

42.2 ± 9.3

12.0 ± 8.5

4.2 ± 3.6

1.6 ± 1.7

3.26 ± 0.35

Data presented as mean ± SD.

Lertratanakul et al. Arthritis Research & Therapy 2012 14(Suppl 3):A21   doi:10.1186/ar3955